All 12 moonwalkers experienced lunar hay fever from toxic dust smelling like gunpowder, underscoring overlooked health and engineering risks critical for sustained human presence as lunar missions accelerate.

The 2018 ESA report documented silicate-based lunar dust causing sore throats, nasal congestion and eye irritation in all Apollo astronauts, with Harrison Schmitt reporting symptoms persisting for days; it cited how the dust's sharpness, lack of atmospheric smoothing and electrostatic levitation allow particles under 10 microns to linger in lungs (ESA 2018). A 2016 NASA Lunar Airborne Dust Toxicity Advisory Group report similarly concluded simulant exposure damaged lung cells, a quantitative risk assessment the original ESA coverage omitted in favor of qualitative description.

Apollo 17 vacuum seal failures and boot abrasion, referenced in the 2008 NASA Apollo Experience Report, connect directly to unaddressed patterns in current Artemis planning; a 2021 Acta Astronautica synthesis of Chang'e-5 regolith data and Apollo samples showed electrostatic charging increases contamination rates by 40% in habitat simulations, an engineering vector missed in 2018 coverage.

ESA's ongoing simulant tests at ESTEC combined with 2022 LADTAG updates and MIT dust mitigation studies indicate chronic silicosis-like effects and solar panel degradation could delay permanent lunar bases; these sources reveal the original article understated the need for electrostatic repulsion tech and advanced airlock designs now required before 2026 crewed landings.